000 | 01986 a2200541 4500 | ||
---|---|---|---|
005 | 20250513125929.0 | ||
264 | 0 | _c19971103 | |
008 | 199711s 0 0 eng d | ||
022 | _a0893-6692 | ||
024 | 7 |
_a10.1002/(sici)1098-2280(1997)30:2<139::aid-em6>3.0.co;2-i _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCollins, A | |
245 | 0 | 0 |
_aComet assay in human biomonitoring studies: reliability, validation, and applications. _h[electronic resource] |
260 |
_bEnvironmental and molecular mutagenesis _c1997 |
||
300 |
_a139-46 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 |
_aAntioxidants _xtherapeutic use |
650 | 0 | 4 | _aDNA Damage |
650 | 0 | 4 | _aDNA Repair |
650 | 0 | 4 | _aDNA-Formamidopyrimidine Glycosylase |
650 | 0 | 4 | _aDeoxyribonuclease (Pyrimidine Dimer) |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xgenetics |
650 | 0 | 4 |
_aElectrophoresis _xmethods |
650 | 0 | 4 |
_aEndodeoxyribonucleases _xgenetics |
650 | 0 | 4 |
_aEnvironmental Monitoring _xmethods |
650 | 0 | 4 | _aEscherichia coli Proteins |
650 | 0 | 4 | _aGenetic Techniques |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydrogen Peroxide _xpharmacology |
650 | 0 | 4 | _aImage Processing, Computer-Assisted |
650 | 0 | 4 |
_aLymphocytes _xdrug effects |
650 | 0 | 4 |
_aN-Glycosyl Hydrolases _xgenetics |
650 | 0 | 4 | _aOccupational Exposure |
650 | 0 | 4 | _aOxidation-Reduction |
650 | 0 | 4 | _aReproducibility of Results |
700 | 1 | _aDusinská, M | |
700 | 1 | _aFranklin, M | |
700 | 1 | _aSomorovská, M | |
700 | 1 | _aPetrovská, H | |
700 | 1 | _aDuthie, S | |
700 | 1 | _aFillion, L | |
700 | 1 | _aPanayiotidis, M | |
700 | 1 | _aRaslová, K | |
700 | 1 | _aVaughan, N | |
773 | 0 |
_tEnvironmental and molecular mutagenesis _gvol. 30 _gno. 2 _gp. 139-46 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/(sici)1098-2280(1997)30:2<139::aid-em6>3.0.co;2-i _zAvailable from publisher's website |
999 |
_c9302564 _d9302564 |